SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination

The receptor‐binding domain (RBD) of the SARS‐CoV‐2 spike protein is a candidate vaccine antigen that binds angiotensin‐converting enzyme 2 (ACE2), leading to virus entry. Here, it is shown that rapid conversion of recombinant RBD into particulate form via admixing with liposomes containing cobalt‐p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Mater
Main Authors: Huang, Wei‐Chiao, Zhou, Shiqi, He, Xuedan, Chiem, Kevin, Mabrouk, Moustafa T., Nissly, Ruth H., Bird, Ian M., Strauss, Mike, Sambhara, Suryaprakash, Ortega, Joaquin, Wohlfert, Elizabeth A., Martinez‐Sobrido, Luis, Kuchipudi, Suresh V., Davidson, Bruce A., Lovell, Jonathan F.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645956/
https://ncbi.nlm.nih.gov/pubmed/33111375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adma.202005637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados